EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antihypertensive Potential of Pistacia lentiscus var. Chia: Molecular Insights and Therapeutic Implications

Panagiotis Efentakis, Lydia Symeonidi, Despoina D Gianniou iD, Eleni V Mikropoulou iD, Panagiota Giardoglou, Dimitrios Valakos iD, Giannis Vatsellas iD, Maria Tsota iD, Nikolaos Kostomitsopoulos iD, Ilias Smyrnioudis iD, Ioannis P Trougakos iD, Maria Halabalaki iD und 2 weitere

Nutrients · 2024

DOI: 10.3390/nu16132152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Panagiotis Efentakis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Zografou, Greece. Hauptthemen laut MEDLINE: Pistacia, Hypertension, Antihypertensive Agents, Blood Pressure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPAnEK 2014-2020, European Union and the Operational Program for Competitiveness, Entrepreneurship and Innovation (EPAnEK 2014–2020).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension poses a significant global health burden and is associated with cardiovascular morbidity. Chios mastic gum (CMG), derived from Pistacia lentiscus var. Chia, shows potential as a phytotherapeutic agent, due to its multifaceted beneficial effects. However, its anti-hypertensive effects and vascular, circulatory, and renal-related dysfunction, have not been thoroughly investigated. Herein, we aimed to explore the antihypertensive potential of CMG, focusing on vascular and renal endothelium, in vivo.

Methods

Two models of hypertension in male rats, induced by Angiotensin II and Deoxycorticosterone acetate (DOCA)–high-salt administration, were utilized. CMG was administered at 220 mg/kg daily for four weeks after hypertension onset and blood pressure was measured non-invasively. Whole blood RNA sequencing, metabolomics, real-time PCR, and Western blot analyses of kidney and aorta tissues were additionally performed.

Results

CMG significantly lowered systolic, diastolic, and mean blood pressure in both models. RNA sequencing revealed that CMG modulated immunity in the Angiotensin II model and metabolism in the DOCA–HS model. CMG downregulated genes related to oxidative stress and endothelial dysfunction and upregulated endothelial markers such as Vegfa. Metabolomic analysis indicated improved endothelial homeostasis via lysophosphatidylinositol upregulation.

Conclusions

CMG emerges as a potent natural antihypertensive therapy, demonstrating beneficial effects on blood pressure and renal endothelial function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PistaciaHypertensionAntihypertensive AgentsBlood PressureAnimalsMaleRatsKidneyMastic ResinDisease Models, AnimalAngiotensin IIRats, Sprague-DawleyDesoxycorticosterone AcetateOxidative StressEndothelium, VascularPlant Extracts

Stichwörter der Autor:innen

chios mastic gumhypertensionphytotherapeuticrenal endothelium

Substanzen

Antihypertensive AgentsMastic ResinAngiotensin IIDesoxycorticosterone AcetatePlant Extracts

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Zografou, Greece.
  • Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, 15784 Athens, Greece.
  • Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.
  • Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University of Athens, 17671 Athens, Greece.
  • Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
  • Greek Genome Centre, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.

ORCID-Profile: Despoina D Gianniou, Eleni V Mikropoulou, Dimitrios Valakos, Giannis Vatsellas, Maria Tsota, Nikolaos Kostomitsopoulos, Ilias Smyrnioudis, Ioannis P Trougakos, Maria Halabalaki, Georgios V Dedoussis, Ioanna Andreadou

Förderung

  • EPAnEK 2014-2020
  • European Union and the Operational Program for Competitiveness, Entrepreneurship and Innovation (EPAnEK 2014–2020)

Zitieren

APA

Efentakis, P., Symeonidi, L., Gianniou, D. D., Mikropoulou, E. V., Giardoglou, P., Valakos, D., Vatsellas, G., Tsota, M., Kostomitsopoulos, N., Smyrnioudis, I., Trougakos, I. P., Halabalaki, M., Dedoussis, G. V., & Andreadou, I. (2024). Antihypertensive Potential of Pistacia lentiscus var. Chia: Molecular Insights and Therapeutic Implications. Nutrients. https://doi.org/10.3390/nu16132152

Vancouver

Efentakis P, Symeonidi L, Gianniou DD, Mikropoulou EV, Giardoglou P, Valakos D, et al. Antihypertensive Potential of Pistacia lentiscus var. Chia: Molecular Insights and Therapeutic Implications. Nutrients. 2024. doi:10.3390/nu16132152

BibTeX
@article{Efentakis2024,
  author = {Efentakis, Panagiotis and Symeonidi, Lydia and Gianniou, Despoina D and Mikropoulou, Eleni V and Giardoglou, Panagiota and Valakos, Dimitrios and Vatsellas, Giannis and Tsota, Maria and Kostomitsopoulos, Nikolaos and Smyrnioudis, Ilias and Trougakos, Ioannis P and Halabalaki, Maria and Dedoussis, Georgios V and Andreadou, Ioanna},
  title = {Antihypertensive Potential of Pistacia lentiscus var. Chia: Molecular Insights and Therapeutic Implications},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16132152}
}
Kostenlos starten →